Premalignant Conditions of the Oral Cavity

• Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
• Άλλοι συγγραφείς: Brennan, Peter A. (Επιμελητής έκδοσης, http://id.loc.gov/vocabulary/relators/edt), Aldridge, Tom (Επιμελητής έκδοσης, http://id.loc.gov/vocabulary/relators/edt), Dwivedi, Raghav C. (Επιμελητής έκδοσης, http://id.loc.gov/vocabulary/relators/edt)
• Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
• Γλώσσα: English
• Έκδοση: Singapore : Springer Singapore : Imprint: Springer, 2019.
• Έκδοση: 1st ed. 2019.
• Σειρά: Head and Neck Cancer Clinics,
• Θέματα: Oncology .; Oncology.

Oral squamous cell carcinoma (SCC) is the 13th commonest cancer worldwide, and the most common cancer in the Asian subcontinent due to the widespread habit of tobacco and betel nut chewing. Despite many advances in diagnosis and treatment, the survival statistics have only marginally improved. Howev...

Πίνακας περιεχομένων:

• Introduction to oral premalignant lesions including epidemiology
• Development, relevant anatomy and physiology of the oral cavity and mucosa
• Basic cellular and molecular biology to include the effects of carcinogens (smoking, alcohol, betel nut, HPV, chronic candida)
• Pathophysiology of the transformation from normal mucosa to invasive malignancy (carcinogenesis) including dysplasia
• Leukoplakia including benign lesions
• Erythroplakia and erythroleukoplakia.-The lichenoid group of diseases including erosive and atrophic lichen planus.-Systemic diseases that are potentially pre-cancerous (iron deficiency anaemic, immunosuppression
• Clinical presentation of oral mucosal premalignant lesions (this will be a larger section), and include high and low risk lesions
• Diagnosis including biopsy techniques and other relevant investigations
• Management of premalignant disease of the oral mucosa with up to date clinical trials and adjuvant therapies. Role of surgery, laser treatments
• The future. .